Price $1,031.52 |
Market Cap
37.32B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
48.2
|
P/B
8.24
|
P/S
12.98
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
45.2
|
Op. Cash Flow
1.01M
|
FCF
22.2
|
|
Op. Margin
33.80%
|
Net Margin
28.40%
|
ROE
16.40%
|
ROI
12.10%
|
|
ROA
14.40%
|
EPS Growth
19.70%
|
Current Ratio
5.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Veru Inc (VERU) | $2.17 | - | - | 85.7M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.46 | - | - | 42.8M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.72 | - | - | 4.6M | Strong Buy |
| Misonix, Inc. (MSON) | $10.20 | - | - | 91.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
